deltatrials
Recruiting PHASE2 INTERVENTIONAL 20-arm NCT04817956

Improving Public Cancer Care by Implementing Precision Medicine in Norway (IMPRESS-N)

Improving Public Cancer Care by Implementing Precision Medicine in Norway A Multi-cohort Phase 2 Treatment Clinical Study Investigating Efficacy of Approved Drugs Outside Indication in Patients With Advanced Cancer

Sponsor: Haukeland University Hospital

Interventions Atezolizumab
Updated 9 times since 2021 Last updated: Feb 28, 2024 Started: Apr 1, 2021 Primary completion: Mar 30, 2040 Completion: Apr 30, 2045
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cancer Metastatic, this trial is actively recruiting participants. The trial is conducted by Haukeland University Hospital and has accumulated 9 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Apr 2021 – ~May 2021 · 30 days · monthly snapshotNot Yet Recruiting~May 2021 – ~Oct 2021 · 5 months · monthly snapshotRecruiting~Oct 2021 – ~Jan 2022 · 3 months · monthly snapshotRecruiting~Jan 2022 – ~Nov 2022 · 10 months · monthly snapshotRecruiting~Nov 2022 – ~Mar 2024 · 16 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshotRecruiting~Mar 2025 – present · 16 months · monthly snapshotRecruiting

Change History

9 versions recorded
  1. Mar 2025 — Present [monthly]

    Recruiting PHASE2

  2. Sep 2024 — Mar 2025 [monthly]

    Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  4. Mar 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

  5. Nov 2022 — Mar 2024 [monthly]

    Recruiting PHASE2

Show 4 earlier versions
  1. Jan 2022 — Nov 2022 [monthly]

    Recruiting PHASE2

  2. Oct 2021 — Jan 2022 [monthly]

    Recruiting PHASE2

  3. May 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

    Status: Not Yet RecruitingRecruiting

  4. Apr 2021 — May 2021 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Haukeland University Hospital
  • Helse Fonna
  • Helse Forde
  • Helse Møre og Romsdal HF
  • Helse Nord-Trøndelag HF
  • Helse Stavanger HF
  • Hospital of Southern Norway Trust
  • Lovisenberg Diakonale Hospital
  • Nordlandssykehuset HF
  • Oslo University Hospital
  • Ostfold Hospital Trust
  • St. Olavs Hospital
  • Sykehuset Innlandet HF
  • Sykehuset Telemark
  • The Hospital of Vestfold
  • University Hospital of North Norway
  • University Hospital, Akershus
  • Vestre Viken Hospital Trust
Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .